Join us in San Diego for the 83rd Scientific Sessions! Registration is now open.
Words matter. Those two words were woven through a Sunday morning address by Alvin C. Powers, MD, ADA President, Medicine & Science. Today’s researchers and clinicians work in a 140-character, […] Read more
How will diabetes be treated in 2021, 100 years after the discovery of insulin? With selective insulin sensitizers, and by preventing beta-cell dedifferentiation in type 2 diabetes and producing insulin […] Read more
Everything you thought you knew about the causes of diabetes is wrong, according to Michael W. Schwartz, MD. Beta-cell dysfunction and insulin resistance are symptoms, not causes. The real problem […] Read more
Nearly 1,400 runners and walkers completed Sunday’s annual [email protected], an early morning run/walk along San Diego Harbor. Bryan Alvarado was the first to finish the course and Jeanine Cordova was the top female finisher. Through Novo Nordisk’s continued support of the American Diabetes Association, the [email protected] was free of charge to registered attendees of the 77th Scientific Sessions. Read more
During Sunday morning’s Joint ADA/JDRF Symposium—Progress towards an Artificial Pancreas, closed-loop insulin delivery systems received mostly glowing reviews from the session’s expert presenters. Roman Hovorka, PhD, from the University of […] Read more
Tuesday’s ADA Presidents Oral Session will highlight this year’s top eight abstracts as selected by the Scientific Sessions Meeting Planning Committee. The two-hour session, which will bring the 77th Scientific […] Read more
Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE) Trial Results 2:15 p.m.–3:15 p.m. Monday Halls G-H Chair: Steven […] Read more
During a Tuesday morning symposium, four researchers will explore the effects of cognitive decline and aging as it relates to diabetes care. They will discuss the psychosomatic effects of out-of-control diabetes and hypoglycemia in conjunction with aging, how to recognize the symptoms of cognitive decline, and what can be done to ensure patients still safely manage their disease. Read more
During Monday afternoon’s symposium Successes with Type 1 Diabetes Complications and Survival, four researchers will review the latest data on the development and progression of type 1 diabetes complications. The two-hour symposium will begin at 4:30 p.m. in room 28. Read more
With more than 20,000 children diagnosed with diabetes every year, the American Diabetes Association strives to provide immersive learning experiences through camp programs each year in 25 states, with 54 […] Read more
During A Monday afternoon Case Studies session, four experts will review the management of four types of diabetes-related nerve injuries and diseases. The two-hour session, Case-Based Management of Neuropathies, will […] Read more
The Diabetes Prevention Program (DPP) started in 1996, but its benefits continue to improve the lives of those with diabetes and prediabetes, according to Brenda Montgomery, RN, MSHS, CDE, ADA […] Read more
The Diabetes Control and Complications Trial (DCCT) did more than confirm that intensive glucose control can reduce the complications and mortality associated with diabetes. It also established the role of […] Read more
Saturday morning’s ADA Diabetes Care Symposium, Diabetes Care and Research through the Ages, explored changes in diabetes treatment over the years with an eye toward improving care in the future. […] Read more
Growing evidence suggests that diabetes, cancer, and other diseases are linked at the metabolic level. Basic research is beginning to unravel those metabolic pathways and suggest potential targets for translational […] Read more
Looking more closely at the developmental origins of pediatric obesity and diabetes will help researchers and clinicians not only develop better ways to treat obesity and diabetes, but perhaps stave […] Read more
Research is uncovering significant information about the role of liver fat in metabolic function, with consequences that extend not only to liver disease but to obesity and diabetes as well. […] Read more
Inhibition of PCSK9 in Dyslipidemia Patients with Diabetes 8:00 a.m.–9:00 a.m., Sunday Ballroom 20A-C Chair: Robert H. Eckel, MD Despite the widespread use of statin therapy, many individuals with diabetes mellitus […] Read more
Sunday afternoon’s Physiology of Nervous System Detection of Hypoglycemia symposium will feature four lectures highlighting the latest research into the complex network of neurons involved in glucose homeostasis. The two-hour […] Read more
During Sunday’s symposium Patient-Reported Outcomes (PROs)—Using Clinic-Based Screening and Intervention to Inform Diabetes Care, four experts will analyze the benefits and considerations of implementing PROs into routine clinical care. The […] Read more
Researchers are leveraging “omics” and genome-wide association studies (GWAS) to identify new therapeutic pathways to treat diabetes, according to presenters at Friday’s symposium Can “Omic” and Genome-Wide Association Studies (GWAS) […] Read more
This year’s ADA Pathway to Stop Diabetes Symposium features six recent award recipients, who will discuss their research supported by the Pathway to Stop Diabetes® initiative. The two-hour session begins […] Read more
Continuous glucose monitoring (CGM) outcomes provide meaningful metrics for clinical trials and diabetes care, but the benefits can’t be demonstrated without a standard set of definitions, according to a panel […] Read more
Although the latest high-density lipoprotein (HDL) clinical trials have not shown protection against cardiovascular disease, HDL research needs to continue, according to Alan T. Remaley, MD, PhD, one of the […] Read more
Sometimes too much of a good thing is not so good. Such is the case with intensive glycemic control in certain populations. Saturday’s symposium Overtreatment in Diabetes Management will examine the […] Read more
During Saturday’s symposium Population Health, Affordable Care Act (ACA), and New Approaches for Dissemination/Implementation of the Diabetes Prevention Program (DPP), four experts will share real-world lessons learned from DPP implementation across the nation. The two-hour session begins at 4:00 p.m. in room 6DE. Read more
Diabetes is a lifestyle disease that requires the person living with the disease to make many daily decisions about diet, activity level, and medications, as well as adequate support to […] Read more
Emerging data show that the gut and the gut microbiome play key roles in metabolic health. From glucose and lipid metabolism to fatty liver disease, obesity, and other conditions, intestinal immunity is an important modulator of both metabolic health and metabolic disease. Read more
During Saturday’s two-hour symposium Diabetes, Drugs and Heart Failure, which begins at 1:45 p.m. in Hall A, four experts will discuss several novel diabetes medications and their impact on heart […] Read more
Researchers have tried many approaches to induce beta cells to proliferate and improve function, and most have failed. But several new approaches have emerged, including embryonic stem cells, genetic-based drug […] Read more
The American Diabetes Association’s 77th Scientific Sessions will be held June 9-13, 2017, at the San Diego Convention Center in San Diego, California. In the final weeks before the meeting, Maureen Gannon, PhD, Chair of the 77th Scientific Sessions Meeting Planning Committee, described a few of the sessions on this year’s program that she’s particularly excited about. Read more
Results from seven major clinical trials will be reported at the Scientific Sessions. Click the link to read a brief overview of each trial from the researchers who will be presenting their latest data. Read more
The Acute and Chronic Complications track at the 77th Scientific Sessions includes more than two dozen symposia, state-of-the-art lectures, and special presentations that will keep clinicians abreast of the latest developments in treating and managing diabetic complications. Read more
On Saturday, June 10, the Exercise Professional Interest Group session The New Physical Activity/Exercise Guidelines for Diabetes (11:30 a.m.–12:30 p.m.) will illustrate how rapidly science and policy are evolving in the Behavioral Medicine, Clinical Nutrition, Education, and Exercise theme area. Read more
Technological advances that are transforming diabetes care will be showcased in the Clinical Diabetes/Therapeutics track at the 77th Scientific Sessions. Read more
A pair of mini-symposia on Friday, June 9, will illustrate how epidemiology and genetics are moving to the fore in diabetes research and treatment. A Researcher’s Guide to Exploring Diabetes Genetic Data in the Type 2 Diabetes Knowledge Portal (11:30 a.m.–12:30 p.m.), which is part of the Epidemiology/Genetics track, will provide an eye-opening tour of the type 2-centric portion of the Accelerating Medicines Partnership (AMP). Read more
Transplantation for the treatment of diabetes remains an ever-evolving goal. As success rates improve with experience and research, the bar for success is set higher and higher. Read more
The Insulin Action/Molecular Metabolism track at the 77th Scientific Sessions includes more than a dozen sessions on the hottest topics in the field. Read more
Obesity is more than a global health epidemic. It’s also a major risk factor for insulin resistance and diabetes. Read more
The Islet Biology/Insulin Secretion track at the 77th Scientific Sessions kicks off on Friday, June 9, with a mini-symposium titled Human Islet Research Network—NIH-Funded Interactive Research Network (12:45 p.m.–1:45 p.m.). Read more